Micro-PET for pre-clinical molecular imaging research in Hong Kong


Grant Data
Project Title
Micro-PET for pre-clinical molecular imaging research in Hong Kong
Principal Investigator
Professor Khong, Pek Lan   (Principal investigator)
Co-Investigator(s)
Dr Zhu Hongyun June   (Co-principal investigator)
Professor Yung Benjamin, Yat-ming   (Co-principal investigator)
Professor Wu Ed Xuekui   (Co-principal investigator)
Professor Wong Wing-tak   (Co-principal investigator)
Professor Wong Ian Chi Kei   (Co-principal investigator)
Dr Wong Cesar Sze-Chuen   (Co-principal investigator)
Professor Tse Hung Fat   (Co-principal investigator)
Professor Tsao George Sai Wah   (Co-principal investigator)
Professor Nicholls John Malcolm   (Co-principal investigator)
Professor Ngan Hextan Yuen Sheung   (Co-principal investigator)
Professor Ng Irene Oi Lin   (Co-principal investigator)
Professor Man Kwan   (Co-principal investigator)
Dr Mak Henry Ka Fung   (Co-principal investigator)
Dr Ma Stephanie Kwai Yee   (Co-principal investigator)
Dr Lui Wai Yan Vivian   (Co-principal investigator)
Professor Leung Anskar Yu Hung   (Co-principal investigator)
Dr Lee Elaine Yuen Phin   (Co-principal investigator)
Dr Chang Raymond Chuen Chung   (Co-principal investigator)
Dr Chan Lawrence, Wing-chi   (Co-principal investigator)
Duration
36
Start Date
2015-06-30
Completion Date
2018-06-29
Amount
4000000
Conference Title
Presentation Title
Keywords
positron emission tomography, pre-clinical, radiotracer, molecular imaging
Discipline
Imaging,Molecular Diagnostics
Panel
Medicine
Sponsor
RGC Collaborative Research Fund (CRF)
HKU Project Code
C7018-14E
Grant Type
Collaborative Research Fund (CRF) - Major Equipment Project
Funding Year
2014/2015
Status
On-going
Objectives
1) To establish a research platform in pre-clinical molecular imaging using a micro-PET, backed by an already operational academic cyclotron and radiotracer lab, and with the potential of synergistic and parallel clinical molecular imaging research in the established PET/CT unit in HKU. 2) To facilitate multi-disciplinary and multi-institutional research in a wide scope of research areas, especially the strategic research theme of Cancer research across Hong Kong. 3) To generate and enhance high impact research outputs and grant awards that encompasses (although not limited to) the research areas of oncology, cardiovascular and neurological diseases. 4) To support partnerships with industry, e.g. pharmaceutical industry for pre-clinical drug testing.